| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
GoodRx Holdings, Inc.
13D/A
Amendment 3
GDRX · 38246G108
|
32.9% |
8/26/2026
Event 8/19/2026
|
|||
| Francisco Partners IV, L.P. | 21.9% | ||||
| Francisco Partners IV-A, L.P. | 11.0% | ||||
| Francisco Partners GP IV, L.P. | 32.9% | ||||
| Francisco Partners GP IV Management Limited | 32.9% | ||||
| Francisco Partners Management, L.P. | 32.9% | ||||
|
GoodRx Holdings, Inc.
13D/A
Amendment 2
GDRX · 38246G108
|
36.0% |
3/18/2025
Event 3/16/2025
|
|||
| Francisco Partners IV, L.P. | 24.0% | ||||
| Francisco Partners IV-A, L.P. | 12.0% | ||||
| Francisco Partners GP IV, L.P. | 36.0% | ||||
| Francisco Partners GP IV Management Limited | 36.0% | ||||
| Francisco Partners Management, L.P. | 36.0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.